Carbohydrate-monophosphoryl lipid A conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse

ACS Chemical Biology

Volumn 7, Issue 1, 2012, Pages 235-240

  Wang, Qianli ^a   Zhou, Zhifang ^a   Tang, Shouchu ^a   Guo, Zhongwu ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CARBOHYDRATE ANTIGEN; GLYCOCONJUGATE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; MONOPHOSPHORYL LIPID A TUMOR ASSOCIATED CARBOHYDRATE ANTIGEN CONJUGATE; PHOSPHORYL LIPID A; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; FEMALE; IMMUNOGENICITY; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; TUMOR IMMUNITY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CANCER VACCINES; CELL LINE, TUMOR; G(M3) GANGLIOSIDE; GLYCOCONJUGATES; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LIPID A; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; NEISSERIA MENINGITIDIS; NEOPLASMS; VACCINATION; VACCINES, SYNTHETIC;

NEISSERIA MENINGITIDIS;

EID: 84862908266     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb200358r     Document Type: Article

References (35)

1. Hakomori, S. (2001) Tumor-associated carbohydrate antigens defining tumor malignancy: Basis for development of anti-cancer vaccines Adv. Exp. Med. Biol. 491, 369-402 (Pubitemid 32595136)
2. Bitton, R. J., Guthmann, M. D., Babri, M. R., Carnero, A. J. L., Alonso, D. F., Fainboim, L., and Gomez, D. E. (2002) Cancer vaccines: An update with special focus on ganglioside antigens (Review) Oncol. Rep. 9, 267-276
3. Kuberan, B. and Lindhardt, R. J. (2000) Carbohydrate based vaccines Curr. Org. Chem. 4, 653-677 (Pubitemid 30339148)
4. Livingston, P. O. (1995) Approaches to augmenting the immunogenicity of melanoma gangliosides: from the whole melanoma cells to ganglioside-KLH conjugate vaccines Immunol. Rev. 145, 147-156
5. Danishefsky, S. J. and Allen, J. R. (2000) From the laboratory to the clinic: A retrospective on fully synthetic carbohydrate-based anticancer vaccines Angew. Chem., Int. Ed. 39, 837-863
6. Pon, R. A. and Jennings, H. J. (2009) Carbohydrate-based antibacterial vaccines, In Carbohydrate-Based Vaccines and Immunotherapies (Guo, Z. and Boons, G.-J., Eds.), pp 117-166, John Wiley & Sons, Inc., Hoboken.
7. Pan, Y. B., Chefalo, P., Nagy, N., Harding, C. V., and Guo, Z. (2005) Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines J. Med. Chem. 48, 875-883 (Pubitemid 40209110)
8. Wu, J. and Guo, Z. (2006) Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines Bioconjugate Chem. 17, 1537-1544 (Pubitemid 44851500)
9. Wang, Q., Zhang, J., and Guo, Z. (2007) Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell Bioorg. Med. Chem. 15, 7561-7567 (Pubitemid 47575927)
10. Buskas, T., Ingale, S., and Boons, G. J. (2005) Towards a fully synthetic carbohydrate-based anticancer vaccine: Synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated Tn antigen Angew. Chem., Int. Ed. 44, 5985-5988 (Pubitemid 41345916)
11. Renaudet, O., BenMohamed, L., Dasgupta, G., Bettahi, I., and Dumy, P. (2008) Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine ChemMedChem 3, 737-741
12. Ingale, S., Wolfert, M. A., Buskas, T., and Boons, G. J. (2009) Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors ChemBioChem 10, 455-463
13. Wilkinson, B. L., Day, S., Malins, L. R., Apostolopoulos, V., and Payne, R. J. (2011) Self-adjuvanting multicmponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like Receptor 2 agonist Pam3CysSer Angew. Chem., Int. Ed. 50, 1635-1639
14. Erridge, C., Bennett-Guerrero, E., and Poxton, I. R. (2002) Structure and function of lipopolysaccharides Microbes Infect. 4, 837-851 (Pubitemid 35247447)
15. Casella, C. R. and Mitchell, T. C. (2008) Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant Cell. Mol. Life Sci. 65, 3231-3240
16. Zhang, Y., Gaekwad, J., Wolfert, M. A., and Boons, G.-J. (2007) Modulation of innate immune responses with synthetic lipid A derivatives J. Am. Chem. Soc. 129, 5200-5216 (Pubitemid 46651398)
17. Persing, D. H., Coler, R. N., Lacy, M. J., Johnson, D. A., Baldridge, J. R., Hershberg, R. M., and Reed, S. G. (2002) Taking toll: lipid A mimetics as adjuvants and immunomodulators Trends Microbiol. 10 (Suppl.) S32-S37
18. Dobrovolskaia, M. A. and Vogel, S. N. (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS Microbes Infect. 4, 903-914 (Pubitemid 34775232)
19. Jonuleit, H., Knop, J., and Enk, A. H. (1996) Cytokines and their effects on maturation, differentiation and migration of dendritic cells Arch. Dermatol. Res. 289, 1-8 (Pubitemid 27011060)
20. Masihi, K. N., Lange, W., Johnson, A. G., and Ribi, E. (1986) Enhancement of chemiluminescence and phagocytic activities by nontoxic and toxic forms of lipid A J. Biol. Response Mod. 5, 462-469 (Pubitemid 17199896)
21. Wang, Q., Xue, J., and Guo, Z. (2009) Synthesis of a monophosphoryl lipid A derivative and its conjugation to a modified form of a tumor-associated carbohydrate antigen GM3 Chem. Commun. (Cambridge, U. K.) 5536-5537
22. Tsuchida, T., Saxton, R. E., Morton, D. L., and Irie, R. F. (1987) Gangliosides of human melanoma J. Natl. Cancer Inst. 78, 45-54 (Pubitemid 17009769)
23. Ollila, D. W., Kelley, M. C., Gammon, G., and Morton, D. L. (1998) Overview of melanoma vaccines: active specific immunotherap for melanoma patients Semin. Surg. Oncol. 14, 328-336 (Pubitemid 28211042)
24. Estevez, F., Carr, A., Solorzano, L., Valiente, O., Mesa, C., Barroso, O., Sierra, G. V., and Fernandez, L. E. (1999) Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP) Vaccine 18, 190-197 (Pubitemid 29432152)
25. Perlmutter, R. M., Hansburg, D., Briles, D. E., Nicolotti, R. A., and Davie, J. M. (1978) Subclass restriction of murine anti-carbohydrate antibodies J. Immunol. 121, 566-572 (Pubitemid 8397246)
26. Greenspan, N. S. and Cooper, L. J. (1992) Intermolecular cooperativity: a clue to why mice have IgG3? Immunol. Today 13, 164-168
27. Markham, R. B., Pier, G. B., and Schreiber, J. R. (1991) The roel of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium Pseudomonas aeruginosa J. Immunol. 146, 316-320
28. Gavin, A. L., Barnes, N., Dijstelbloem, H. M., and Hogarth, P. M. (1998) Cutting edge: Identification of the mouse IgG3 receptor: Implications for antibody effector function at the interface between innate and adaptive immunity J. Immunol. 160, 20-23 (Pubitemid 28116709)
29. Guy, B. (2009) Adjuvants for protein- and carbohydrate-based vaccines, In Carbohydrate-Based Vaccines and Immunotherapies (Guo, Z. and Boons, G.-J., Eds.), pp 89-116, John Wiley & Sons, Inc., Hoboken.
30. Kanegasaki, S., Tanamoto, K., Yasuda, T., Homma, J. Y., Matsuura, M., Nakatsujka, M., Kumazawa, Y., Yamamoto, A., Shiba, T., Kusumoto, S., Imoto, M., Yoshimura, H., and Shimamoto, T. (1986) Structure-activity relationship of lipid A: Comparison of biological activities of natural and synthetic lipid A's with different fatty acid compositions J. Biochem. 99, 1203-1210 (Pubitemid 16090604)
31. Buskas, T., Li, Y., and Boons, G. J. (2004) The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrierfprotein Chemistry 10, 3517-3524
32. Tang, S., Wang, Q., and Guo, Z. (2010) Synthesis of a monophosphoryl derivative of Escherichia coli lipid A and its efficient coupling to a tumor-associated carbohydrate antigen Chem.? - ?Eur. J. 16, 1319-1325
33. Wang, Q., Ekanayaka, S. A., Wu, J., Zhang, J., and Guo, Z. (2008) Synthetic and immunological studies of 5?-N-phenylacetyl sTn to develop carbohydrate-based cancer vaccines and to explore the impacts of linkage between carbohydrate antigens and carrier proteins Bioconjugate Chem. 19, 2060-2068
34. Hirabayashi, Y., Hamaoka, A., Matsumoto, M., Matsubara, T., Tagawa, M., Wakabayashi, S., and Taniguchi, M. (1985) Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma J. Biol. Chem. 260, 13328-13333 (Pubitemid 16209811)
35. Chefalo, P., Pan, Y., Nagy, N., Harding, C., and Guo, Z. (2006) Effective metabolic engineering of GM3 on tumor cells by N -phenylacetyl- d -mannosamine Biochemistry 45, 3733-3739